Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

Authors :: Black, Dennis M.
Delmas, Pierre D.
Eastell, Richard
Reid, Ian R.
Boonen, Steven
Cauley, Jane A.
Cosman, P.H. Felicia
Lakatos, Peter
Ping Chung Leung
Man, Zulema
Mautalen, Carlos
Mesenbrink, Peter
Huilin Hi
Caminis, John
Tong, Karen
Rosario-Jansen, Theresa
Krasnow, Joel
Hue, Trisha F.
Sellmeyer, Deborah
Eriksen, Erik Fink
Cummings, Steven R.
Source :: The New England Journal of Medicine. May 3, 2007, Vol. 356 Issue 18, p1809, 15 p.
Publication Year :: 2007
Abstract: The effects of annual infusion of zoledronic acid in postmenopausal women are assessed. This dose was found to improve the bone density and reduce the risk of osteoporotic fractures over a period of three years.

Subjects :: Osteoporosis -- Drug therapy
Postmenopausal women -- Health aspects
Zoledronic acid -- Dosage and administration
Zoledronic acid -- Complications and side effects

Tools